Ikena Oncology | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Regulatory Trial results

29 May 2024

Ikena rolls over on Hippo

Trial results

10 November 2023

Nothing like Hippo for cooling investor enthusiasm

Ikena is savaged in a bear market after reporting zero remissions in a dose-escalation trial of its lead asset.

Subscribe to Ikena Oncology